Show simple item record

dc.contributor.authorWorld Health Organization, Regional Office for South-East Asia
dc.coverage.spatialNew Delhien_US
dc.date.accessioned2016-05-11T05:45:59Z
dc.date.available2016-05-11T05:45:59Z
dc.date.issued2010
dc.identifier.govdocSEA-CD-204
dc.identifier.urihttps://apps.who.int/iris/handle/10665/206200
dc.description.abstractThe Third Meeting of the Regional Technical Advisory Group (‎RTAG)‎ on kala-azar elimination was held on 8-11 December 2009 in Dhaka, Bangladesh, to review and discuss the kala-azar situation as well as recommend a drug of choice for the Kala-azar Elimination Programme. The currently recommended drug miltefosine has been found to have limited compliance and has teratogenic effects during pregnancy as suggested by experiments on animals. There were reservations about using the drug for the treatment of women of child bearing age. Hence, single dose ambisome has been recommended for the Programme after its feasibility was demonstrated in field conditions. The RTAG meeting discussed vector control methods and monitoring and evaluation of the progress of the Programme. Indicators for such activities were also developed and endorsed. This report synopsizes the deliberations at the meeting and its recommendations.en_US
dc.language.isoenen_US
dc.publisherWHO Regional Office for South-East Asiaen_US
dc.subjectKALA AZARen_US
dc.titleRegional technical advisory group on kala-azar eliminationen_US
dc.title.alternativereport of the third meeting, Dhaka, Bangladesh, 8-11 December 2009en_US
dc.typeMeeting reportsen_US


Files in this item

Thumbnail

This item appears in the following Collection(‎s)‎

Show simple item record